tirzepatide levothyroxine Possible pro-oncogenic effect of (TRZD) on the thyroid Hashimoto's Thyroiditis: Tirzepatide Case Report

Administration instructions Administer once weekly, any time of day, with or without meals

Eligibility Zepbound vials carry the same FDA indications as the autoinjector pens: Chronic weight management: adults with BMI 30, or BMI 27 with at least one weight-related condition (type 2 diabetes, high blood pressure, high cholesterol, or OSA) used alongside reduced-calorie diet and increased physical activity

Constipation (moderately worse) Alcohol is dehydrating

Ideal candidates are those with obesity resistant to lifestyle interventions and no contraindicating medical conditions

This means the FDA has not reviewed them for safety, effectiveness, or quality